Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07024875 · ClinicalTrials.gov registry record
Neuroimaging of Parkinson's
A clinical trial of Parkinsons Disease (PD), sponsored by Washington University School of Medicine.
- Recruiting
- Registry status
- 120
- Enrollment target
- 1
- Study location
NCT07024875 is a study of Parkinsons Disease (PD) that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 120 participants, roughly in line with the 113-participant average among 19 other Parkinsons Disease (PD) trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT07024875, a study of Parkinsons Disease (PD), is actively recruiting participants, sponsored by Washington University School of Medicine.
- RECRUITING
- Registry status
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
Parkinson's Disease (PD) is a neurodegenerative disorder caused by dysfunction in both subcortical structures and the cortex. The investigators recently discovered a new brain system called the Somato-Cognitive Action Network (SCAN), which could be a primary locus of dysfunction in PD. Here, the investigators will use magnetic resonance imaging techniques in PD patients to test whether SCAN is critical for PD. The investigators will determine whether SCAN is connected to PD-relevant subcortical structures, and whether PD patients exhibit altered subcortical-to-SCAN connectivity. If successful, this work will identify SCAN as a specific circuit altered in PD patients that can serve as a new target for future neuromodulatory PD therapies.
Conditions Studied
Study Locations (1)
Missouri
- East Imaging Building - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2025-08-01 |
| Est. Completion | 2031-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07024875
The ClinicalTrials.gov registry entry for NCT07024875 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 113-participant average among 19 other Parkinsons Disease (PD) trials with a reported enrollment target. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Parkinsons Disease (PD) appearing as the primary indexed condition, and to 0 interventions.
NCT07024875 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT07024875 about?
NCT07024875 is a clinical study titled "Neuroimaging of Parkinson's". Parkinson's Disease (PD) is a neurodegenerative disorder caused by dysfunction in both subcortical structures and the cortex. The investigators recently discovered a new brain system called the Somato-Cognitive Action Network (SCAN), which could be a primary locus of dysfunction in PD. Here, the inv...
What is the current status of trial NCT07024875?
This trial is currently recruiting. The enrollment target is 120 participants. The study started on 2025-08-01. Estimated completion is 2031-01.
What conditions does trial NCT07024875 study?
This clinical trial studies the following conditions: Parkinsons Disease (PD).
Who is sponsoring clinical trial NCT07024875?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07024875 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinsons Disease (PD)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Transcranial Direct Current Stimulation for Motor Function and Fatigue in PD
RECRUITING · NA
-
A Study of NE3107 in Early Parkinson's
RECRUITING · Phase 2
-
Study to Investigate Vagus Nerve Stimulation to Augment Executive Function in Healthy and Cognitively Impaired Populations
RECRUITING · NA
-
Enrichment of Glutathione Using Gamma-glutamylcysteine Supplementation in Parkinson's Disease Patients.
RECRUITING · Phase 1
-
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
RECRUITING · Phase 3
-
Investigating Subcortical Contributions to Speech Sequencing in Deep Brain Stimulator Recipients
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.